MyDosageBeta
Where to buyCheck a brandAbout us
Early access Nº 01

Pick your way. We'll email you the day it opens.

Free. Tell us where you are and which way you want — a prescriber, a compounding pharmacy, or checked research-use-only suppliers.

Get started
  • Early access
  • Where to buy
  • Check a brand
  • Scan my product
  • Guide me
The three ways
  • Approved medicines
  • Compounding pharmacies
  • Lab (RUO) suppliers
Understand
  • Goals
  • Conditions
  • Side effects
  • Dose calculator
  • Research
About
  • About us
  • How we check
  • Manifesto
  • For brands
  • Apply to be listed
  • For clinicians

*These statements have not been evaluated by any medicines agency. Nothing on MyDosage is intended to diagnose, treat, cure or prevent any disease. Research-use-only compounds are not approved for human use. Always talk to a clinician before changing what you take.

© 2026 MyDosage. All rights reserved.
PrivacyTermsFor clinicians
DashboardCheck
Peptides/HCG
Glycoprotein hormone

HCG

Glycoprotein hormone used for ovulation induction and male hypogonadism. Strictly clinical.

Human RCT · t½ ~24–36 h · 500–5000 IU per protocol

Start with a product

Pick what you have. We'll guide the rest.

Schedule, what to expect, side-effects to watch — built around your exact product.

Scan a productAdd manually
AHuman RCT evidenceHuman RCTGlycoprotein hormone

Also: Human chorionic gonadotropin · Pregnyl · Ovidrel

Glycoprotein hormone used for ovulation induction and male hypogonadism. Strictly clinical.

Scientific Consensus Engine

Evidence Intelligence Score™

Heuristic — no indexed evidence yet
6.4/ 10
Overall confidence
Moderate
Outlook
Moderate
Evidence maturity
  1. Preclinical
  2. Pilot human
  3. RCT← current
  4. Multi-RCT
  5. Meta-analysis

Confidence aggregates eight dimensions of evidence — human data, safety maturity, mechanism, clinical readiness, momentum, consistency, long-term follow-up, and translational signal. It is a measure of what is known, not a recommendation. Methodology.

Eight-dimension breakdown
  1. Human evidence
    Weight of RCT and observational data
    8.8
  2. Safety maturity
    Follow-up depth and adverse-event signal
    6.9
  3. Mechanism confidence
    Pathway specificity and clarity
    6.4
  4. Clinical readiness
    Distance to physician-prescribable use
    7.8
  5. Research momentum
    Recency of indexed clinical evidence
    5.0
  6. Study consistency
    Effect direction across cohorts
    3.0
  7. Long-term data
    Follow-up beyond initial trial windows
    5.4
  8. Translational confidence
    Animal → human signal preservation
    7.7
Strongest supported claim

Effects on the indexed outcomes are supported by randomized human data, with 1 citation on file.

Weakest / unclear

Effect sizes outside trial populations and durations beyond the studied window remain less characterized.

Major unknowns

Interactions outside listed contraindications, long-term safety, and effect heterogeneity across age and sex are not fully resolved.

Scientific outlook

Outlook: maturing. Expect the consensus to harden as multi-site replications publish.

Mechanism
LH receptor agonist; stimulates ovarian steroidogenesis and testicular Leydig cells.
Citations
  • FDA — Pregnyl label
What we don't know yet
  • —Long-term safety beyond reported study durations.
  • —Effect size in populations under-represented in the cited trials.
  • —Interactions with concomitant medications outside listed contraindications.

We surface uncertainty next to every claim. Suggestive, never prescriptive — discuss with a clinician.

Editorial team
Independent · No affiliate revenue
Reviewed quarterly
Typical dose500–5000 IU per protocol
Half-life~24–36 h
RoutesSubcutaneous · Intramuscular
Evidence tierHuman RCT
Safety confidence
Short
Mid
Long-term

No indexed safety data yet — bars reflect editorial tier baseline.

Contraindications
  • — Hormone-sensitive tumours
  • — Pregnancy

Suggestive, never prescriptive. Discuss with a clinician.

Brands carrying this peptide

2 brands across three tiers.

Medicine

2 brands

Regulator-approved finished medicines. Prescribed for specific indications, manufactured under GMP, distributed through licensed pharmacies.

  • Pregnyl
    Organon
    500–10000 IU per protocol
    FDA-approved · EMA · MHRA
    →
  • Ovidrel
    Merck Serono
    250 mcg (≈6500 IU) single dose
    FDA-approved · EMA · MHRA
    →